Skip to main content

Advertisement

SpringerLink
Log in

Increased thyroid cancer risk in acromegaly

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Acromegaly increases cancer risk. We aimed to determine the prevalence and the predictors of tumors in acromegalic patients treated at our department. We retrospectively evaluated 160 acromegalic patients [79 female (mean age 52.0 ± 10.4 years) and 81 male (mean age 49.1 ± 12.4 years)] between 1990 and 2012, with a mean follow up period of 7.1 ± 5.7 years. The patients were screened with colonoscopy, mammography, thyroid and prostate ultrasonography. Malignancy was found in 34 (21.3 %) patients. No significant difference was observed in the distribution of malignancy among sexes (20.3 % in F vs. 22.2 % in M). Thyroid cancer was the most frequent (n = 17, 10.6 %) followed by the breast cancer (n = 4, 2.5 %) and colorectal cancer (n = 3, 1.8 %). Renal cell cancer in two patients, bladder cancer in two patients, periampullary tumor, rectal carcinoid tumor, malignant melanoma, prostate cancer, lung cancer, parotid mucoepidermoid carcinoma and malignant mesenchymal tumor in brain in one patient were detected. One patient had both thyroid and renal cell cancer. Age of patients at diagnosis of acromegaly was significantly higher in patients with cancer (45.8 ± 9.9 vs. 40.9 ± 11.3 years, p < 0.05). No significant difference was found in duration of the disease, initial GH levels and IGF-1 % upper limit of normal values, the prevalence of diabetes, hypertension, coronary heart disease, hyperlipidemia and treatment modalities between the patients with/without cancer. In logistic regression analysis, older age at diagnosis was associated with malignancy risk. The risk of cancer in acromegaly especially the thyroid cancer risk seems to be more increased than known in the literature. Therefore, acromegaly patients should be screened routinely for cancer, especially for thyroid cancer due to it being up to four times higher prevalence than breast and colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barzilay J, Heatley GJ, Cushing GW (1991) Benign and malignant tumors in patients with acromegaly. Arch Intern Med 151(8):1629–1632

    Article  CAS  PubMed  Google Scholar 

  2. Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M, Obradovic S, Zoric S, Simic M, Penezic Z, Marinkovic J, The Pituitary Study Group (1998) Increased incidence of neoplasia in patients with pituitary adenomas. Clin Endocrinol (Oxf) 49(4):441–445

    Article  CAS  Google Scholar 

  3. Jenkins PJ, Besser M (2001) Clinical perspective: acromegaly and cancer: a problem. J Clin Endocrinol Metab 86(7):2935–2941

    Article  CAS  PubMed  Google Scholar 

  4. Melmed S (2001) Acromegaly and cancer: not a problem? J Clin Endocrinol Metab 86(7):2929–2934

    Article  CAS  PubMed  Google Scholar 

  5. Ayuk J, Sheppard MC (2008) Does acromegaly enhance mortality? Rev Endocr Metab Disord 9(1):3339. doi:10.1007/s11154-007-9067-8

    Article  Google Scholar 

  6. Renehan AG, Brennan BM (2008) Acromegaly, growth hormone and cancer risk. Best Pract Res Clin Endocrinol Metab 22(4):639–657. doi:10.1016/j.beem.2008.08.011

    Article  CAS  PubMed  Google Scholar 

  7. Prisco M, Romano G, Peruzzi F, Valentinis B, Baserga R (1999) Insulin and IGF-I receptors signaling in protection from apoptosis. Horm Metab Res 31(2–3):80–89. doi:10.1055/s-2007-978703

    Article  CAS  PubMed  Google Scholar 

  8. Remacle-Bonnet MM, Garrouste FL, Heller S, Andre F, Marvaldi JL, Pommier GJ (2000) Insulin like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways. Cancer Res 60(7):2007–2017

    CAS  PubMed  Google Scholar 

  9. Jenkins PJ (2006) Cancers associated with acromegaly. Neuroendocrinology 83(3–4):218–223. doi:10.1159/000095531

    Article  CAS  PubMed  Google Scholar 

  10. Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83(8):2730–2734

    CAS  PubMed  Google Scholar 

  11. Bayram F, Gedik VT, Demir O, Kaya A, Gundogan K, Emral R, Ozturk A, Uysal AR, Corapcioglu D (2011) Epidemiologic survey: reference ranges of serum insulin-like growth factor 1 levels in Caucasian adult population with immunoradiometric assay. Endocrine 40(2):304–309. doi:10.1007/s12020-011-9476-z

    Article  CAS  PubMed  Google Scholar 

  12. Mustacchi P, Shimkin MB (1957) Occurrence of cancer in acromegaly and in hypopituitarism. Cancer 10(1):100–104

    Article  CAS  PubMed  Google Scholar 

  13. Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, Olsen JH, Baron JA, Fraumeni JF Jr (2002) Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 13(5):395–400

    Article  CAS  PubMed  Google Scholar 

  14. Higuchi Y, Saeki N, Iuchi T, Uchino Y, Tatsuno I, Uchida D, Tanaka T, Noguchi Y, Nakamura S, Yasuda T, Yamaura A, Sunami K, Oka Y, Uozumi A (2000) Incidence of malignant tumors in patients with acromegaly. Endocr J 47(Suppl):S57–S60

    Article  PubMed  Google Scholar 

  15. Vallette S, Ezzat S, Chik C, Ur E, Imran SA, Uum S, Rivera J, Caspar-Bell G, Serri O (2012) Emerging trends in the diagnosis and treatment of acromegaly in Canada. Clin Endocrinol (Oxf). doi:10.1111/cen.12112

    Google Scholar 

  16. Bates AS, Van’t Hoff W, Jones PJ, Clayton RN (1996) The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 81(3):1169–1172

    CAS  PubMed  Google Scholar 

  17. Eser S, Yakut C, Ozdemir R, Karakilinc H, Ozalan S, Marshall SF, Karaoglanoglu O, Anbarcioglu Z, Ucuncu N, Akin U, Ozen E, Ozgul N, Anton-Culver H, Tuncer M (2010) Cancer incidence rates in Turkey in 2006: a detailed registry based estimation. Asian Pac J Cancer Prev 11(6):1731–1739

    PubMed  Google Scholar 

  18. Gullu BE, Celik O, Gazioglu N, Kadioglu P (2010) Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 13(3):242–248. doi:10.1007/s11102-010-0224-9

    Article  PubMed  Google Scholar 

  19. Miyakawa M, Saji M, Tsushima T, Wakai K, Shizume K (1988) Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels. J Clin Endocrinol Metab 67(5):973–978

    Article  CAS  PubMed  Google Scholar 

  20. Kasagi K, Shimatsu A, Miyamoto S, Misaki T, Sakahara H, Konishi J (1999) Goiter associated with acromegaly: sonographic and scintigraphic findings of the thyroid gland. Thyroid 9(8):791–796

    Article  CAS  PubMed  Google Scholar 

  21. Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, Mariotti S, Colao AM, Lombardi G, Baldelli R, Camanni F, Liuzzi A (2002) Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest 25(3):240–245

    Article  CAS  PubMed  Google Scholar 

  22. Cheung NW, Boyages SC (1997) The thyroid gland in acromegaly: an ultrasonographic study. Clin Endocrinol (Oxf) 46(5):545–549

    Article  CAS  Google Scholar 

  23. Loeper S, Ezzat S (2008) Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord 9(1):41–58. doi:10.1007/s11154-007-9063-z

    Article  CAS  PubMed  Google Scholar 

  24. Dogan S, Atmaca A, Dagdelen S, Erbas B, Erbas T (2013) Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients. Endocrine. doi:10.1007/s12020-013-9981-3

    Google Scholar 

  25. Erdogan G, Erdogan MF, Emral R, Bastemir M, Sav H, Haznedaroglu D, Ustundag M, Kose R, Kamel N, Genc Y (2002) Iodine status and goiter prevalence in Turkey before mandatory iodization. J Endocrinol Invest 25(3):224–228

    Article  CAS  PubMed  Google Scholar 

  26. Erdogan MF, Agbaht K, Altunsu T, Ozbas S, Yucesan F, Tezel B, Sargin C, Ilbeg I, Artik N, Kose R, Erdogan G (2009) Current iodine status in Turkey. J Endocrinol Invest 32(7):617–622. doi:10.3275/6379

    Article  CAS  PubMed  Google Scholar 

  27. Erdogan G, Erdogan MF, Delange F, Sav H, Gullu S, Kamel N (2000) Moderate to severe iodine deficiency in three endemic goitre areas from the Black Sea region and the capital of Turkey. Eur J Epidemiol 16(12):1131–1134

    Article  CAS  PubMed  Google Scholar 

  28. Tita P, Ambrosio MR, Scollo C, Carta A, Gangemi P, Bondanelli M, Vigneri R, degli Uberti EC, Pezzino V (2005) High prevalence of differentiated thyroid carcinoma in acromegaly. Clin Endocrinol (Oxf) 63(2):161–167. doi:10.1111/j.1365-2265.2005.02316.x

    Article  Google Scholar 

  29. Kurimoto M, Fukuda I, Hizuka N, Takano K (2008) The prevalence of benign and malignant tumors in patients with acromegaly at a single institute. Endocr J 55(1):67–71. doi:10.1507/endocrj.K07E-010

    Article  PubMed  Google Scholar 

  30. Dos Santos MC, Nascimento GC, Nascimento AG, Carvalho VC, Lopes MH, Montenegro R, Montenegro R Jr, Vilar L, Albano MF, Alves AR, Parente CV, Dos Santos Faria M (2013) Thyroid cancer in patients with acromegaly: a case-control study. Pituitary 16(1):109–114. doi:10.1007/s11102-012-0383-y

  31. Clero E, Doyon F, Chungue V, Rachedi F, Boissin JL, Sebbag J, Shan L, Bost-Bezeaud F, Petitdidier P, Dewailly E, Rubino C, de Vathaire F (2012) Dietary iodine and thyroid cancer risk in French Polynesia: a case-control study. Thyroid 22(4):422–429. doi:10.1089/thy.2011.0173

    Article  CAS  PubMed  Google Scholar 

  32. Ozdemir D, Dagdelen S, Kiratli P, Tuncel M, Erbas B, Erbas T (2012) Changing clinical characteristics of thyroid carcinoma at a single center from Turkey: before and after the Chernobyl disaster. Minerva Endocrinol 37(3):267–274

    CAS  PubMed  Google Scholar 

  33. Tramontano D, Cushing GW, Moses AC, Ingbar SH (1986) Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves’-IgG. Endocrinology 119(2):940–942

    Article  CAS  PubMed  Google Scholar 

  34. Minuto F, Barreca A, Del Monte P, Cariola G, Torre GC, Giordano G (1989) Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. J Clin Endocrinol Metab 68(3):621–626

    Article  CAS  PubMed  Google Scholar 

  35. Onoda N, Ohmura E, Tsushima T, Ohba Y, Emoto N, Isozaki O, Sato Y, Shizume K, Demura H (1992) Autocrine role of insulin-like growth factor (IGF)-I in a human thyroid cancer cell line. Eur J Cancer 28A(11):1904–1909

    Article  CAS  PubMed  Google Scholar 

  36. Nabarro JD (1987) Acromegaly. Clin Endocrinol 26(4):481–512

    Article  CAS  Google Scholar 

  37. Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vazquez JA, Zamora J, Albareda M, Gilabert M (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). European journal of endocrinology/European Federation of Endocrine Societies 151(4):439–446

    Article  CAS  PubMed  Google Scholar 

  38. Emerman JT, Leahy M, Gout PW, Bruchovsky N (1985) Elevated growth hormone levels in sera from breast cancer patients. Horm Metab Res 17(8):421–424. doi:10.1055/s-2007-1013563

    Article  CAS  PubMed  Google Scholar 

  39. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J, Demaille A (1993) Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 29A(4):492–497

    Article  CAS  PubMed  Google Scholar 

  40. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351(9113):1393–1396. doi:10.1016/S0140-6736(97)10384-1

    Article  CAS  PubMed  Google Scholar 

  41. Mertani HC, Garcia-Caballero T, Lambert A, Gerard F, Palayer C, Boutin JM, Vonderhaar BK, Waters MJ, Lobie PE, Morel G (1998) Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer 79(2):202–211

    Article  CAS  PubMed  Google Scholar 

  42. Pollak MN (1998) Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention. Breast Cancer Res Treat 47(3):209–217

    Article  CAS  PubMed  Google Scholar 

  43. Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni JF Jr (1991) Acromegaly and gastrointestinal cancer. Cancer 68(8):1673–1677

    Article  CAS  PubMed  Google Scholar 

  44. Bogazzi F, Russo D, Locci MT, Chifenti B, Ultimieri F, Raggi F, Cosci C, Sardella C, Costa A, Gasperi M, Bartalena L, Martino E (2005) Apoptosis is reduced in the colonic mucosa of patients with acromegaly. Clin Endocrinol 63(6):683–688. doi:10.1111/j.1365-2265.2005.02405.x

    Article  CAS  Google Scholar 

  45. Dutta P, Bhansali A, Vaiphei K, Dutta U, Ravi Kumar P, Masoodi S, Mukherjee KK, Varma A, Kochhar R (2012) Colonic neoplasia in acromegaly: increased proliferation or deceased apoptosis? Pituitary 15(2):166–173. doi:10.1007/s11102-011-0300-9

    Article  CAS  PubMed  Google Scholar 

  46. Bustin SA, Dorudi S, Phillips SM, Feakins RM, Jenkins PJ (2002) Local expression of insulin-like growth factor-I affects angiogenesis in colorectal cancer. Tumour Biol 23(3):130–138. doi:10.1159/000064029

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, School of Medicine, Hacettepe University, Sihhiye, 06100, Ankara, Turkey

    Selcuk Dagdelen, Nese Cinar & Tomris Erbas

Authors
  1. Selcuk Dagdelen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nese Cinar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomris Erbas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomris Erbas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dagdelen, S., Cinar, N. & Erbas, T. Increased thyroid cancer risk in acromegaly. Pituitary 17, 299–306 (2014). https://doi.org/10.1007/s11102-013-0501-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-013-0501-5

Keywords

Search

Navigation